Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Elsevier
Publish with us
Press release

Featured articles from the journal CHEST®, September 2022

Glenview, IL | September 20, 2022

Published monthly, the journal CHEST(opens in new tab/window)® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The September issue(opens in new tab/window) of CHEST journal contains 40 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activities(opens in new tab/window), including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“With September serving as pulmonary fibrosis awareness month, I recommend reading original research such as “Disparities in Rural Populations With Idiopathic Pulmonary Fibrosis(opens in new tab/window),” published in the September issue, which finds that rural participants with idiopathic pulmonary fibrosis present with worse disease severity compared with their suburban counterparts,” says Editor-in-Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “Lung diseases like pulmonary fibrosis and more in the fields of pulmonary, critical care and sleep medicine will be covered extensively at the upcoming CHEST Annual Meeting(opens in new tab/window) in Nashville, Oct. 16-19. The journal CHEST will publish all presented abstracts one week before the conference begins, and authors will speak to the research live at the meeting.”

Also included in the current issue of the journal CHEST:

  • Asthma

Original research, “Asthma Control, Airway Mucus, and 129Xe MRI Ventilation After a Single Benralizumab Dose(opens in new tab/window),” finds that improved airway function can be measured directly after a first benralizumab dose and that the presence of airway mucus could influence this potential response.

  • Critical Care

Nationwide study, “Factors Associated With Spontaneous Awakening Trial and Spontaneous Breathing Trial Performance in Adults With Critical Illness(opens in new tab/window),” demonstrates that nonmodifiable (age, admitting ICU diagnosis and BMI) and modifiable (ICU symptoms, physical restraint use, use of a target sedation level, etc.) factors influence spontaneous awakening trial and spontaneous breathing trial performance. A visual abstract for the research can be viewed here(opens in new tab/window).

Infographic showing what factors are associated with spontaneous awakening trial (SAT) and spontaneous breathing trial (SBT)

What Factors Are Associated With Spontaneous Awakening Trial (SAT) and Spontaneous Breathing Trial (SBT) Performance? (Credit: Michele C. Balas, PhD, RN, CCRN-K, et al. CHEST September 2022 https://doi.org/10.1016/j.chest.2022.01.018(opens in new tab/window)).

  • Sleep

A state-of-the-art review, “Sex and Gender in Lung Disease and Sleep Disorders(opens in new tab/window),” provides a look into specific effects of sex and gender focused on epidemiology, disease presentation, risk factors and management of lung diseases.

  • Thoracic Oncology

The Association of Health Care System Resources With Lung Cancer Screening Implementation(opens in new tab/window)” indicates that policies that increase system-level resources within the Veterans Health Administration could improve lung cancer screening reach and sustainability. An animation of this research can be viewed here(opens in new tab/window).

---

Notes for editors

To view the entire September issue of CHEST journal (volume 162, issue 3), published by Elsevier, visit journal.chestnet.org(opens in new tab/window) and follow @journal_CHEST(opens in new tab/window) on Twitter for the latest journal news.

Full text of these articles and interviews with the authors are available to credentialed journalists upon request; contact Laura DiMasi, PR and Communications Specialist, American College of Chest Physicians (CHEST), at [email protected](opens in new tab/window).

About the journal CHEST®

The journal CHEST(opens in new tab/window), the official publication of the American College of Chest Physicians®, features the best in peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care, and sleep medicine; thoracic surgery; cardiorespiratory interactions; and related disciplines. Published since 1935, it is home to the highly regarded clinical practice guidelines and consensus statements. Access the journal CHEST online at journal.chestnet.org(opens in new tab/window).

About the American College of Chest Physicians

The American College of Chest Physicians® (CHEST) is the global leader in the prevention, diagnosis, and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication, and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.(opens in new tab/window)

About Elsevier

As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray’s Anatomy.

Together with the Elsevier Foundation(opens in new tab/window), we work in partnership with the communities we serve to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX(opens in new tab/window), a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com.

Contact

LD

Laura DiMasi

PR and Communications Specialist

American College of Chest Physicians (CHEST)

E-mail Laura DiMasi